4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-011832
Chief Executive Officer sold 356,546 shares at an average $157.99 ($56,330,724)
- Chief Executive Officer acquired 208,708 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Leproust Emily M. · Chief Executive Officer
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +133,269 | $26.66 | $3,552,952 | 901,696 | D |
| 2026-09-17 | Exercise or conversion : show line 2 in the form 10b5-1 | +75,439 | $8.82 | $665,372 | 977,135 | D |
| 2026-09-17 | Sale : show line 3 in the form 10b5-1 | −2,440 | $151.46 | $369,566 | 974,695 | D |
| 2026-09-17 | Sale : show line 4 in the form 10b5-1 | −6,644 | $152.21 | $1,011,291 | 968,051 | D |
| 2026-09-17 | Sale : show line 5 in the form 10b5-1 | −3,399 | $153.40 | $521,417 | 964,652 | D |
| 2026-09-17 | Sale : show line 6 in the form 10b5-1 | −4,175 | $154.17 | $643,661 | 960,477 | D |
| 2026-09-17 | Sale : show line 7 in the form 10b5-1 | −13,378 | $155.46 | $2,079,701 | 947,099 | D |
| 2026-09-17 | Sale : show line 8 in the form 10b5-1 | −9,097 | $156.47 | $1,423,384 | 938,002 | D |
| Open-market sales · 356,546 sh · avg $157.99 · $56,330,724 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-17 | Exercise or conversion : show line 16 in the form 10b5-1 Employee Stock Option (right to buy) | −75,439 | 0 | D |
| 2026-09-17 | Exercise or conversion : show line 17 in the form 10b5-1 Employee Stock Option (right to buy) | −133,269 | 0 | D |
Loading xslF345X06/marketforms-74024.xml…